RhumbLine Advisers’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-52,824
| Closed | -$979K | – | 4307 |
|
2023
Q3 | $979K | Buy |
52,824
+16,205
| +44% | +$300K | ﹤0.01% | 2225 |
|
2023
Q2 | $405K | Buy |
36,619
+2,436
| +7% | +$26.9K | ﹤0.01% | 2824 |
|
2023
Q1 | $459K | Buy |
34,183
+1,089
| +3% | +$14.6K | ﹤0.01% | 2477 |
|
2022
Q4 | $409K | Buy |
33,094
+1,598
| +5% | +$19.7K | ﹤0.01% | 2559 |
|
2022
Q3 | $439K | Buy |
31,496
+2,087
| +7% | +$29.1K | ﹤0.01% | 2552 |
|
2022
Q2 | $406K | Buy |
29,409
+1,210
| +4% | +$16.7K | ﹤0.01% | 2604 |
|
2022
Q1 | $459K | Sell |
28,199
-3,832
| -12% | -$62.4K | ﹤0.01% | 2458 |
|
2021
Q4 | $522K | Sell |
32,031
-323
| -1% | -$5.26K | ﹤0.01% | 2490 |
|
2021
Q3 | $480K | Buy |
32,354
+1,001
| +3% | +$14.9K | ﹤0.01% | 2565 |
|
2021
Q2 | $626K | Buy |
31,353
+500
| +2% | +$9.98K | ﹤0.01% | 2457 |
|
2021
Q1 | $712K | Sell |
30,853
-1,256
| -4% | -$29K | ﹤0.01% | 2337 |
|
2020
Q4 | $793K | Buy |
32,109
+749
| +2% | +$18.5K | ﹤0.01% | 2250 |
|
2020
Q3 | $1.3M | Sell |
31,360
-9,685
| -24% | -$401K | ﹤0.01% | 1888 |
|
2020
Q2 | $1.97M | Buy |
41,045
+4,603
| +13% | +$220K | ﹤0.01% | 1740 |
|
2020
Q1 | $2.29M | Buy |
36,442
+594
| +2% | +$37.4K | ﹤0.01% | 1474 |
|
2019
Q4 | $4.44M | Buy |
35,848
+3,139
| +10% | +$389K | 0.01% | 1325 |
|
2019
Q3 | $2.17M | Sell |
32,709
-55
| -0.2% | -$3.65K | ﹤0.01% | 1699 |
|
2019
Q2 | $2.61M | Buy |
32,764
+3,850
| +13% | +$306K | ﹤0.01% | 1577 |
|
2019
Q1 | $3.23M | Sell |
28,914
-225
| -0.8% | -$25.2K | 0.01% | 1427 |
|
2018
Q4 | $2.94M | Buy |
29,139
+9,470
| +48% | +$955K | 0.01% | 1421 |
|
2018
Q3 | $2.49M | Sell |
19,669
-1,484
| -7% | -$187K | ﹤0.01% | 1539 |
|
2018
Q2 | $1.78M | Buy |
21,153
+2,181
| +11% | +$183K | ﹤0.01% | 1732 |
|
2018
Q1 | $1.17M | Sell |
18,972
-492
| -3% | -$30.3K | ﹤0.01% | 1873 |
|
2017
Q4 | $1.14M | Sell |
19,464
-475
| -2% | -$27.7K | ﹤0.01% | 1889 |
|
2017
Q3 | $1.16M | Sell |
19,939
-305
| -2% | -$17.7K | ﹤0.01% | 1897 |
|
2017
Q2 | $2.45M | Buy |
20,244
+713
| +4% | +$86.3K | 0.01% | 1452 |
|
2017
Q1 | $2.21M | Sell |
19,531
-25
| -0.1% | -$2.83K | 0.01% | 1488 |
|
2016
Q4 | $2.13M | Buy |
19,556
+1,536
| +9% | +$167K | 0.01% | 1412 |
|
2016
Q3 | $2.97M | Buy |
18,020
+727
| +4% | +$120K | 0.01% | 1161 |
|
2016
Q2 | $2.47M | Buy |
17,293
+1,675
| +11% | +$239K | 0.01% | 1203 |
|
2016
Q1 | $2.01M | Sell |
15,618
-231
| -1% | -$29.7K | 0.01% | 1377 |
|
2015
Q4 | $2.37M | Buy |
15,849
+109
| +0.7% | +$16.3K | 0.01% | 1245 |
|
2015
Q3 | $2.61M | Buy |
15,740
+580
| +4% | +$96.2K | 0.01% | 1172 |
|
2015
Q2 | $3.66M | Buy |
15,160
+4,250
| +39% | +$1.03M | 0.01% | 1026 |
|
2015
Q1 | $3.08M | Buy |
10,910
+725
| +7% | +$204K | 0.01% | 1113 |
|
2014
Q4 | $1.59M | Sell |
10,185
-1,635
| -14% | -$255K | ﹤0.01% | 1506 |
|
2014
Q3 | $2.8M | Buy |
11,820
+1,942
| +20% | +$460K | 0.01% | 1095 |
|
2014
Q2 | $2.34M | Buy |
9,878
+2,799
| +40% | +$662K | 0.01% | 1266 |
|
2014
Q1 | $2.34M | Buy |
7,079
+702
| +11% | +$232K | 0.01% | 1249 |
|
2013
Q4 | $435K | Buy |
6,377
+590
| +10% | +$40.2K | ﹤0.01% | 2344 |
|
2013
Q3 | $399K | Buy |
5,787
+95
| +2% | +$6.55K | ﹤0.01% | 2357 |
|
2013
Q2 | $255K | Buy |
+5,692
| New | +$255K | ﹤0.01% | 2784 |
|